Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic viral hepatitis C. Part 1. General considerations].

V P Conte1

  • 1Departamento de Gastroenterologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP.

Arquivos De Gastroenterologia
|March 10, 2001
PubMed
Summary

Hepatitis C virus (HCV) infection is primarily transmitted through blood and drug use. While screening has reduced post-transfusion cases, understanding HCV genotypes and their impact on disease severity is crucial for developing effective vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Chronic hepatitis by C virus. Part 2. Treatment].

Arquivos de gastroenterologia·2001
Same author

[Hepatocellular carcinoma. Part 2. Treatment].

Arquivos de gastroenterologia·2001
Same author

[Hepatocellular carcinoma. Part 1. General considerations and diagnosis].

Arquivos de gastroenterologia·2000
Same author

[Oddi's sphincter dysfunction].

Revista do Hospital das Clinicas·1991
Same author

Normal neuronal features of the human gallbladder and structural changes in cholelithiasis patients.

Revista do Hospital das Clinicas·1989
Same author

[Non-surgical treatment of biliary lithiasis].

Revista do Hospital das Clinicas·1989

Area of Science:

  • Hepatology and Virology: Focus on Hepatitis C Virus (HCV) and novel DNA virus (TTV).
  • Immunology: Exploring immune responses to HCV envelope E2 protein and vaccine development.
  • Epidemiology: Analyzing HCV genotype distribution and transmission routes.

Context:

  • Hepatitis C virus (HCV) identified in 1989 as the main cause of non-A, non-B hepatitis.
  • High prevalence linked to blood transfusions and intravenous drug abuse.
  • Advancements in screening have reduced post-transfusion hepatitis incidence.

Purpose:

  • To review the natural history, epidemiology, and clinical significance of Hepatitis C virus infection.
  • To explore the association between HCV genotypes and disease severity.
  • To discuss potential vaccine development strategies and the role of novel viruses like TTV.

Summary:

Related Experiment Videos

  • HCV genotype distribution varies geographically, with subtypes 1a, 3a, and 1b being most prevalent.
  • Subtype 1b is associated with a more severe disease course, mitochondrial dysfunction, and impaired oxidative phosphorylation.
  • Intrahepatic HCV levels are not determined by host or viral factors, and negative serum RT-PCR does not rule out liver infection.

Impact:

  • Understanding genotype-specific disease progression aids in targeted treatment and management.
  • Research into immune modulation and novel vaccine strategies offers hope for controlling highly mutable HCV.
  • Further investigation is needed to clarify the pathogenic role of TTV and its association with disease.